Rallybio CorporationRLYBNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
31.14%
↑ 781% above average
Average (22q)
-4.57%
Historical baseline
Range
High:31.14%
Low:-50.33%
Volatility
-1781.1%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 31.14% |
| Q2 2025 | -4.00% |
| Q1 2025 | 16.70% |
| Q4 2024 | 3.80% |
| Q3 2024 | 29.17% |
| Q2 2024 | 13.91% |
| Q1 2024 | 6.28% |
| Q4 2023 | -9.03% |
| Q3 2023 | 3.59% |
| Q2 2023 | -9.30% |
| Q1 2023 | -7.51% |
| Q4 2022 | 9.38% |
| Q3 2022 | -7.07% |
| Q2 2022 | -23.03% |
| Q1 2022 | -16.28% |
| Q4 2021 | -23.36% |
| Q3 2021 | 5.21% |
| Q2 2021 | 17.89% |
| Q1 2021 | -27.13% |
| Q4 2020 | -50.33% |
| Q3 2020 | -43.93% |
| Q2 2020 | -21.28% |
| Q1 2020 | 0.00% |